ELIZABETH MORTON: Open Payments
NPI 1538160957 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$943 in 45 payments from 15 companies in 2025. Trend: 2023 $1,487 · 2024 $1,533 · 2025 $943
Food & beverage: $819Education: $124
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $224 |
| Hill Dermaceuticals, Inc. | 1 | $96 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $95 |
| GENZYME CORPORATION | 4 | $83 |
| Novartis Pharmaceuticals Corporation | 4 | $68 |
| Regeneron Healthcare Solutions, Inc. | 4 | $68 |
| E.R. Squibb & Sons, L.L.C. | 4 | $65 |
| ABBVIE INC. | 3 | $64 |
| Cipher Pharmaceuticals US LLC | 1 | $46 |
| Amgen Inc. | 2 | $34 |
Products named: TREMFYA, DUPIXENT, Tolak, COSENTYX, Sotyktu, SKYRIZI, Natroba, OTEZLA.
Industry payments across KY — which companies pay providers there.
